MedPath

Can serum value of NT-proBNP be used in predicting patient outcome for those with preeclampsia admitted to IC

Not Applicable
Conditions
Health Condition 1: O14- Pre-eclampsia
Registration Number
CTRI/2023/05/053056
Lead Sponsor
CMS and GTB Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All preeclamptic obstetric patients (pregnant or within 6 weeks postdelivery), admitted to our multidisciplinary ICU will be included. Diagnosis of preeclampsia will be made as per existing guidelines of American College of Obstetricians and Gynaecologists

Exclusion Criteria

Those with history of prior cardiac disease or renal disease will be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DeathTimepoint: Will be evaluated daily, starting from day of admission in ICU till end of hospital stay.
Secondary Outcome Measures
NameTimeMethod
Duration of ICU stay (days)Timepoint: From day of ICU admission till discharge/death in IC
© Copyright 2025. All Rights Reserved by MedPath